tiprankstipranks
PTC Therapeutics reports Q1 EPS ($1.20), consensus ($1.24)
PremiumThe FlyPTC Therapeutics reports Q1 EPS ($1.20), consensus ($1.24)
3d ago
PTC Therapeutics submits MAA for sepiapterin in PKU to EMA
PremiumThe Fly
PTC Therapeutics submits MAA for sepiapterin in PKU to EMA
1M ago
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
1M ago
PTC Therapeutics price target lowered to $30 from $32 at TD Cowen
PremiumThe FlyPTC Therapeutics price target lowered to $30 from $32 at TD Cowen
2M ago
PTC Therapeutics Q4 and Fiscal Year-End Financial Update Call
PremiumCompany Announcements
PTC Therapeutics Q4 and Fiscal Year-End Financial Update Call
2M ago
PTC Therapeutics sees FY24 revenue $600M-$680M, consensus $612.29M
PremiumThe Fly
PTC Therapeutics sees FY24 revenue $600M-$680M, consensus $612.29M
2M ago
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
PTC Therapeutics put buyer realizes 42% same-day gains
PremiumThe Fly
PTC Therapeutics put buyer realizes 42% same-day gains
2M ago
PTC Therapeutics price target lowered to $43 from $45 at JPMorgan
PremiumThe Fly
PTC Therapeutics price target lowered to $43 from $45 at JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100